SCHEMBL9302534

SCHEMBL9302534

O=P(O)(O)C(N1CCC(c2ccccc2)CC1)P(=O)(O)O

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.49
HRH3 Q9Y5N1 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
OPRM1 P35372 1/20 0.47
SLC18A3 Q16572 8/20 0.46
FDPS P14324 2/20 0.44
CYP2D6 P10635 2/20 0.44
SIGMAR1 Q99720 2/20 0.44
TSHR P16473 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
ALDH1A1 P00352 1/20 0.43
APEX1 P27695 1/20 0.43
BLM P54132 1/20 0.43
GRIN2B Q13224 1/20 0.42
DRD2 P14416 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9300979 0.84 OPRM1 (0.49) KCNH2HRH3L3MBTL1OPRM1SLC18A3
SCHEMBL9301335 0.76 KCNH2 (0.52) KCNH2HRH3OPRM1SIGMAR1GRIN2B
SCHEMBL2661616 0.74 KCNH2 (0.56) KCNH2HRH3OPRM1SLC18A3CYP2D6
SCHEMBL27498941 0.73 KCNH2 (0.60) KCNH2HRH3L3MBTL1OPRM1SLC18A3
SCHEMBL6221180 0.73 SLC18A3 (0.48) KCNH2HRH3OPRM1SLC18A3SIGMAR1
SCHEMBL2603282 0.73 HRH3 (0.69) KCNH2HRH3OPRM1SLC18A3CYP2D6
SCHEMBL7060188 0.72 SLC18A3 (0.50) KCNH2HRH3L3MBTL1SLC18A3CYP2D6
Phosphoric Acid SCHEMBL27640844 0.72 SLC18A3 (0.49) SLC18A3CYP2D6SIGMAR1TSHRSMN1; SMN2
SCHEMBL6190526 0.72 KCNH2 (0.51) KCNH2HRH3L3MBTL1OPRM1SLC18A3
SCHEMBL753850 0.72 LMNA (0.63) KCNH2HRH3L3MBTL1OPRM1SLC18A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5350743-A Treatment of osteoporosis KAKEN PHARMACEUTICAL CO., LTD. (JP) 1994-09-27 US disclosed
EP-0498424-A1 Bisphosphonic acid derivatives and bone resorption inhibitors containing them Kaken Pharmaceutical Co., Ltd. (JP) 1992-08-12 EP disclosed